I am on vacation this week, so guest editing 20/20 Glance is Modern Optometry's Editor-in-Chief, Karen Roman, and Publisher, Sarah Aemisegger.
The war against unsavory contact lens business practices continues.
The AAO recently reached out to its Fellows and members in support of the AOA and the profession of optometry. The organization asked for state Attorney Generals to be contacted and for public comments to be submitted to the FTC before the comment period closed on July 29th regarding a contact lens rule proposal by the FTC./p>
What’s the proposed new rule issued earlier this year?
The FTC’s contact lens rule proposal would require all eye doctors to obtain and store evidence that they provided each patient with a copy of their contact lens prescription.
Hasn’t this been an ongoing issue?
For more than 2 years the AOA has opposed the FTC recommendation to require contact lens prescribers to obtain a signed form from their contact lens-wearing patients after providing the prescription for fear that these requirements would create an additional burden on doctors and their patients. Click here for additional background. The AOA continues to urge the FTC to withdraw its burdensome requirements and to target illegal contact lens sales and other anti-patient abuses.
What’s the status?
As a result of thousands of calls, emails, and letters, 22 US Senators have so far joined a bipartisan effort launched by Sens. James Lankford (R-OK) and Krysten Sinema (D-AZ) to urge the FTC not to finalize its updated Contact Lens Rule plan. Whether that sways the FTC remains to be seen. Now, we wait.
Everyone, go buy nosebleed seats to your favorite band.
New contact lenses that can zoom in or out by blinking twice? A recent paper describes a novel human–machine interface developed to use electrooculographic signals generated by eye movements to control the motions and the change of focal length of a biomimetic soft lens. (via)
WHAT YOUR PATIENT MIGHT ASK YOU
Is there a non drop alternative to treating dry eye?
It is in the works. Oyster Point Pharma announced enrollment of the first subject in the phase 3 ONSET-2 clinical trial of OC-01 Nasal Spray for the treatment of the signs and symptoms of dry eye disease.
Here’s the background:
Results from the phase 2b ONSET-1 clinical trial showed significant improvements in both the prespecified primary sign endpoint and multiple prespecified secondary symptom endpoints. (via)
SOCIAL MEDIA ROUNDUP
Alexa, am I having a heart attack?
Alexa can help with many health care functions, such as tracking blood glucose levels, post-surgical care instructions, and at-home prescription delivery monitoring. But after winning a lawsuit to use protected patient health records, Alexa is no longer limited to generic responses about medical conditions. She will soon be able to send and receive individualized patient records, discern when someone is ill and suggest solutions, and potentially send vitals to a doctor’s office before your appointments. What can’t Alexa do? (via)
AMD can’t keep Dame Judi down.
Many know that Oscar winner Dame Judi Dench has age-related macular degeneration (AMD). She was diagnosed in 2012 and has the dry form in one eye and the wet form in another, but anti-VEGF injections haven’t been able to slow the progression of the disease. Dame Judi may not be able to read a newspaper or book or do crossword puzzles anymore, but she gets by just fine with large print scripts, an RSS news reader, and by relying on friends and others to help her navigate the world. (via)